WALTHAM, Mass.–(BUSINESS WIRE)–NeuroMetrix, Inc. (Nasdaq: NURO), reported that Quell was featured on
ABC’s Good Morning America on September 17 in a segment titled “Erase
Your Pain”. Good Morning America is the #1 morning show in the US,
reaching nearly 5 million households each week. In the segment, Quell
user and Physical Therapist Valerie Gregory shared how the device has
eased her osteoarthritis pain. Quell is a new, innovative,
over-the-counter wearable pain relief device that utilizes patented
OptiTherapy technology to provide widespread pain relief.
In addition to last week’s appearance on Good Morning America, Quell has
been featured in a number of other influential articles, reports, blogs,
and interviews. Highlights include:
Quell has been featured in local broadcast news in 17 markets such as
the WCIU (NBC) Chicago segment titled “Quell
Device for Chronic Pain”. Additional segments aired in Atlanta
(NBC), Washington DC (ABC), Las Vegas (ABC) and Portland (Fox).
CEO, Shai N. Gozani, M.D., Ph.D., was interviewed by Medscape
at the PAINWeek Scientific Sessions, “Wearable
Nerve Stimulator Improves Chronic Pain”.
New clinical evidence that 81% of Quell users reported improvement in
chronic pain and overall health was featured in several outlets
including The Boston Globe “Research
Says Quell Zaps Pain”.
Potential future indications for the device were picked up by Sleep
RLS Patients, NeuroMetrix Reports Positive Pilot Data for its Wearable
Pain Relief Technology”.
Quell debuted on QVC
on September 2, where the product was the featured innovation in the
“We are encouraged by the increase in national and broadcast coverage
over the last several weeks,” said Shai N. Gozani, M.D., Ph.D.,
President and Chief Executive Officer of NeuroMetrix. “Quell directly
addresses the chronic pain struggles of millions of Americans and we
look forward to expanding awareness of the product’s unique benefits so
that more chronic pain sufferers can experience relief.”
About Quell Wearable Pain Relief Device
Quell is an easy-to-use, over-the-counter device for relief of chronic
pain. This wearable device utilizes NeuroMetrix’s wearable intensive
nerve stimulation (WINS) technology to provide pain relief. In a recent
clinical study, Quell improved chronic pain and overall health in 81% of
participants. Quell is currently available through select healthcare
professionals, retailers and online at www.QuellRelief.com.
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
Thomas T. Higgins, 781-314-2761
Chief Financial Officer